Chapter 1 General Provisions
Article 1 To protect the legitimate rights and interests of the company, shareholders, employees, and creditors, and to regulate the organization and conduct of the company, these Articles of Association are formulated in accordance with the "Company Law of the People's Republic of China" (hereinafter referred to as the "Company Law"), the "Securities Law of the People's Republic of China" (hereinafter referred to as the "Securities Law"), and other relevant regulations.
Article 2 Harbin Gloria Pharmaceuticals Co., Ltd. (hereinafter referred to as the "Company") is a foreign-invested stock company established in accordance with the "Company Law" and other relevant regulations.
The Company was approved by the Ministry of Commerce of the People's Republic of China, Shang Zi Pi [2008] No. 659, and was jointly initiated by Harbin Hengshida Chang Technology Co., Ltd., Yu Heng International Investments Corporation (Heng Sheng International Investment Company), Oriental Keystone Investment Limited (Health Technology Investment Company), and Bai Geng Yu Feng (Beijing) Investment Consulting Co., Ltd. It was established as a foreign-invested stock company through the overall transformation of Harbin Gloria Pharmaceuticals Co., Ltd. based on its audited net assets. The Company obtained the "Approval Certificate for Foreign-Invested Enterprises of the People's Republic of China" Shang Wai Zi Shen Pi [2008] No. 0139 on June 10, 2008, and was registered with the Administration for Industry and Commerce of Heilongjiang Province on June 26, 2008, obtaining the "Enterprise Legal Person Business License" with registration number 230000400002254.